| Astellas Pharma Inc. v. Ascent Pharms., Inc., 25-0035 (D.N.J.) |
Jan. 2, 2025 |
Hon. Michael A. Shipp |
Xtandi®
(enzalutamide tablets) |
7,709,517
8,183,274
12,161,628 |
| Avadel CNS Pharms., LLC v. Jazz Pharms., Inc., 25-0009 (D. Del.) |
Jan. 3, 2025 |
Hon. Gregory B. Williams |
Lumryz®
(sodium oxybate extended-release oral suspension) |
12,167,991 |
| Acacia Pharma Ltd. v. Galenicum Health S.L.U., 25-0010 (D. Del.) |
Jan. 3, 2025 |
Hon. Gregory B. Williams |
Byfavo®
(remimazolam for injection) |
9,561,236
9,827,251 |
| Nexus Pharms., LLC v. Hikma Pharms. USA Inc., 25-0018 (D. Del.) |
Jan. 6, 2025 |
Hon. Gregory B. Williams |
Emerphed®
(ephedrine sulfate for injection) |
11,464,752
11,426,369
11,571,398 |
| Avadel CNS Pharms., LLC v. Jazz Pharms., Inc., 25-0021 (D. Del.) |
Jan. 7, 2025 |
Hon. Gregory B. Williams |
Lumryz®
(sodium oxybate extended-release oral suspension) |
12,186,298 |
| Amneal Pharms. LLC v. Sandoz Inc., 25-0181 (D.N.J.) |
Jan. 7, 2025 |
Hon. Georgette Castner |
Crexont®
(carbidopa / levodopa extended-release capsules) |
10,098,845
10,292,935
10,688,058
10,973,769
10,987,313
11,357,733
11,622,941
11,666,538
11,986,449
12,064,521
12,109,185
12,128,141 |
| AstraZeneca Pharms. LP v. Natco Pharma Ltd., 25-0230 (D.N.J.) |
Jan. 9, 2025 |
Hon. Robert Kirsch |
Lynparza®
(olaparib tablets) |
12,178,816 |
| AstraZeneca Pharms. LP v. Sandoz Inc., 25-0231 (D.N.J.) |
Jan. 9, 2025 |
Hon. Robert Kirsch |
Lynparza®
(olaparib tablets) |
12,178,816 |
| AstraZeneca Pharms. LP v. Cipla Ltd., 25-0233 (D.N.J.) |
Jan. 9, 2025 |
Hon. Robert Kirsch |
Lynparza®
(olaparib tablets) |
12,178,816 |
| AstraZeneca Pharms. LP v. Zydus Pharms. (USA) Inc., 25-0234 (D.N.J.) |
Jan. 9, 2025 |
Hon. Robert Kirsch |
Lynparza®
(olaparib tablets) |
12,178,816 |
| Azurity Pharms., Inc. v. Exelixis, Inc., IPR2025-00427 (PTAB) |
Jan. 9, 2025 |
N/A |
Cometriq®
(cabozantinib S-malate capsules) Cabometyx®
(cabozantinib S-malate tablets) |
12,128,039 |
| Ascerta Pharma B.V. v. MSN Pharms. Inc., 25-0043 (D. Del.) |
Jan. 10, 2025 |
Hon. Gregory B. Williams |
Calquence®
(acalabrutinib maleate tablets) |
10,272,083
11,059,829 |
| Astellas Pharma Inc. v. Creekwood Pharms. LLC, 25-0045 (D. Del.) |
Jan. 10, 2025 |
Hon. Joseph F. Bataillon |
Myrbetriq®
(mirabegron extended-release tablets) |
10,842,780
11,707,451
12,059,409
12,097,189 |
| Bausch Health Ireland Ltd. v. Mylan Pharms. Inc., 25-0003 (N.D.W.V.) |
Jan. 13, 2025 |
Hon. Thomas S. Kleeh |
Trulance®
(plecanatide tablets) |
12,146,003 |
| Avadel CNS Pharms., LLC v. Jazz Pharms., Inc., 25-0057 (D. Del.) |
Jan. 14, 2025 |
Hon. Gregory B. Williams |
Lumryz®
(sodium oxybate extended-release oral suspension) |
12,186,298 |
| Astellas Pharma Inc. v. Hikma Pharms. USA Inc., 25-0578 (D.N.J.) |
Jan. 16, 2025 |
Hon. Michael A. Shipp |
Xtandi®
(enzalutamide tablets) |
11,839,689
12,161,628 |
| Eagle Pharms., Inc. v. Apotex Inc., 25-0074 (D. Del.) |
Jan. 17, 2025 |
Hon. Jennifer L. Hall |
Belrapzo®
(bendamustine HCl injection) |
12,138,248 |
| Eagle Pharms., Inc. v. Slayback Pharma LLC, 25-0075 (D. Del.) |
Jan. 17, 2025 |
Hon. Jennifer L. Hall |
Belrapzo®
(bendamustine HCl injection) |
12,138,248 |
| Eagle Pharms., Inc. v. Baxter Healthcare Corp., 25-0079 (D. Del.) |
Jan. 17, 2025 |
Hon. Jennifer L. Hall |
Belrapzo®
(bendamustine HCl injection) |
12,138,248 |
| Padagis US LLC v. Neurelis, Inc., IPR2025-00464 (PTAB) |
Jan. 17, 2025 |
N/A |
Valtoco®
(diazepam nasal spray) |
8,895,546 |
| Padagis US LLC v. Neurelis, Inc., IPR2025-00465 (PTAB) |
Jan. 17, 2025 |
N/A |
Valtoco®
(diazepam nasal spray) |
11,241,414 |
| Padagis US LLC v. Neurelis, Inc., IPR2025-00466 (PTAB) |
Jan. 17, 2025 |
N/A |
Valtoco®
(diazepam nasal spray) |
11,793,786 |
| CSPC Pharm. Group Ltd. v. Ipsen Biopharm Ltd., IPR2025-00505 (PTAB) |
Jan. 17, 2025 |
N/A |
Onivyde®
(irinotecan HCl injection) |
11,344,552 |
| Novartis Pharms. Corp. v. MSN Labs. Private Ltd., 25-0081 (D. Del.) |
Jan. 17, 2025 |
Hon. Richard G. Andrews |
Entresto®
(sacubitril / valsartan tablets) |
8,101,659 |
| Axsome Malta Ltd. v. Aurobindo Pharma USA, Inc., 25-0643 (D.N.J.) |
Jan. 21, 2025 |
Hon. Madeline Cox Arleo |
Sunosi®
(solriamfetol tablets) |
12,102,609 |
| Merck Sharp & Dohme B.V. v. USV Private Ltd., 25-0694 (D.N.J.) |
Jan. 23, 2025 |
Hon. Claire C. Cecchi |
Bridion®
(sugammadex injection) |
RE44,733 |
| Harmony Biosciences Management, Inc. v. Lupin Ltd., 25-0102 (D. Del.) |
Jan. 24, 2025 |
Hon. Jennifer L. Hall |
Wakix®
(pitolisant HCl tablets) |
8,486,947
8,207,197 |
| American Regent, Inc. v. Xiromed, LLC, 25-0723 (D.N.J.) |
Jan. 24, 2025 |
Hon. Brian R. Martinotti |
Tralement®
(trace elements injection of zinc, copper, manganese, selenium) |
11,786,548
11,975,022
11,998,565
12,150,956
12,150,957 |
| Axsome Malta Ltd. v. Hetero USA Inc., 25-0801 (D.N.J.) |
Jan. 29, 2025 |
Hon. Madeline Cox Arleo |
Sunosi®
(solriamfetol tablets) |
12,102,609 |
| Apotex Inc. v. Alkermes Pharma Ireland Ltd., IPR2025-00514 (PTAB) |
Jan. 30, 2025 |
N/A |
Vivitrol®
(naltrexone extended-release suspension) |
7,919,499 |
| Intra-Cellular Therapies, Inc. v. Zydus Pharms. (USA) Inc., 25-0898 (D.N.J.) |
Jan. 31, 2025 |
Hon. Michael A. Shipp |
Caplyta®
(lumateperone capsules) |
9,956,227
10,960,009
11,026,951
RE48,839 |
| Celgene Corp. v. Cipla Ltd., 25-1147 (D.N.J.) |
Feb. 10, 2025 |
Hon. Esther Salas |
Pomalyst®
(pomalidomide capsules) |
8,828,427
9,993,467
10,555,939 |
| Bausch & Lomb Inc. v. Sandoz Inc., 25-1167 (D.N.J.) |
Feb. 11, 2025 |
Hon. Michael E. Farbiarz |
Lotemax®
SM (loteprednol etabonate ophthalmic gel) |
10,596,107
11,534,395 |
| Novartis Pharms. Corp. v. Cipla Ltd., 25-0186 (D. Del.) |
Feb. 14, 2025 |
Hon. Colm F. Connolly |
Mayzent®
(siponimod tablets) |
8,492,441
11,944,602
12,071,402 |
| Acadia Pharms. Inc. v. Zydus Lifesciences Ltd., 25-0187 (D. Del.) |
Feb. 14, 2025 |
Hon. Gregory B. Williams |
Nuplazid®
(pimavenserin tablets) |
7,601,740
7,659,285
7,732,615
10,517,860
10,953,000 |
| Otsuka Pharm. Co., Ltd. v. Alvogen, Inc., 25-0188 (D. Del.) |
Feb. 14, 2025 |
Hon. Jennifer L. Hall |
Abilify Maintena®
(aripiprazole injection) |
10,525,057
10,980,803
11,154,553
11,344,547
11,400,087
11,648,347 |
| AbbVie Inc. v. Hetero USA, Inc., 25-0190 (D. Del.) |
Feb. 14, 2025 |
Hon. Maryellen Noreika |
Rinvoq®
(upadacitinib extended-release tablets) |
11,607,411
11,564,922 |
| American Regent, Inc. v. Meitheal Pharms., Inc., 25-0191 (D. Del.) |
Feb. 14, 2025 |
Hon. Gregory B. Williams |
Selenious Acid |
11,998,565
12,150,957 |
| American Regent, Inc. v. Meitheal Pharms., Inc., 25-1278 (D.N.J.) |
Feb. 14, 2025 |
Hon. Brian R. Martinotti |
Selenious Acid |
11,998,565
12,150,957 |
| Vifor (Int’l) AG v. Apotex Inc., 25-0211 (D. Del.) |
Feb. 20, 2025 |
Hon. Colm F. Connolly |
Injectafer®
(ferric carboxymaltose injection) |
7,612,109
7,754,702
8,895,612
11,364,260
11,433,091
11,478,502 |
| Metacel Pharms. LLC v. Rubicon Research Private Ltd., 25-1382 (D.N.J.) |
Feb. 20, 2025 |
Hon. Evelyn Padin |
Ozobax®
(baclofen oral solution) |
10,610,502 |
| Novartis Pharms. Corp. v. Cipla Ltd., 25-0216 (D. Del.) |
Feb. 21, 2025 |
Hon. Gregory B. Williams |
Tasingna®
(nilotinib d-tartrate capsules) |
8,389,537 |
| Merck Sharp & Dohme LLC v. Sun Pharm. Indus. Ltd., 25-1424 (D.N.J.) |
Feb. 24, 2025 |
Hon. Claire C. Cecchi |
Dificid®
(fidaxomicin tablets) |
7,906,489
7,378,508
7,863,249
8,859,510 |
| Genentech, Inc. v. Zydus Lifesciences Global FZE, 25-1521 (D.N.J.) |
Feb. 27, 2025 |
Hon. Brian R. Martinotti |
Evrysdi®
(risdiplam solution) |
12,122,789 |
| Azurity Pharms., Inc. v. Heron Therapeutics, Inc., PGR2025-00035 (PTAB) |
Feb. 28, 2025 |
N/A |
Cinvanti®
(aprepitant injection) Aponvie®
(aprepitant injection) |
12,115,254 |
| Azurity Pharms., Inc. v. Heron Therapeutics, Inc., PGR2025-00036 (PTAB) |
Feb. 28, 2025 |
N/A |
Cinvanti®
(aprepitant injection) Aponvie®
(aprepitant injection) |
12,115,255 |
| Astellas Pharma Inc. v. Deva Holding A/S, 25-0233 (D. Del.) |
Feb. 28, 2025 |
Hon. Maryellen Noreika |
Myrbetriq®
(mirabegron extended-release tablets) |
10,842,780
11,707,451
12,059,409
12,097,189 |
| Endo USA, Inc. v. Baxter Healthcare Corp., 25-2365 (N.D. Ill.) |
Mar. 5, 2025 |
Hon. Franklin U. Valderrama |
Adrenalin®
(epinephrine in 0.9% sodium chloride injection) |
11,071,719
11,207,280
12,133,837 |
| Novo Nordisk Inc. v. Mylan Pharms. Inc., 25-0276 (D. Del.) |
Mar. 10, 2025 |
Hon. Colm F. Connolly |
Wegovy®
(semaglutide injection) |
12,214,017 |
| BioCryst Pharms., Inc. v. Annora Pharma Private Ltd., 25-0281 (D. Del.) |
Mar. 10, 2025 |
Hon. Jennifer L. Hall |
Orladeyo®
(berotralstat dihydrochloride capsules) |
10,662,160
11,117,867
11,618,733 |
| Nevakar Injectables, Inc. v. Baxter Healthcare Corp., 25-0301 (D. Del.) |
Mar. 11, 2025 |
Hon. Christopher J. Burke |
Norepinephrine bitartrate injection |
12,245,996 |
| Sumitomo Pharma Switzerland GmbH v. Apotex Inc., 25-0311 (D. Del.) |
Mar. 12, 2025 |
Hon. Maryellen Noreika |
Orgovyx®
(relugolix tablets) |
11,795,178
12,097,198
12,144,809 |
| Sumitomo Pharma Switzerland GmbH v. Cipla Ltd., 25-0312 (D. Del.) |
Mar. 12, 2025 |
Hon. Maryellen Noreika |
Orgovyx®
(relugolix tablets) |
11,795,178
12,097,198
12,144,809 |
| Otsuka Pharm. Co., Ltd. v. Alkem Labs. Ltd., 25-0318 (D. Del.) |
Mar. 13, 2025 |
Hon. Richard G. Andrews |
Jynarque®
(tolvaptan tablets) |
8,501,730
10,905,694
8,273,735 |
| Incyte Corp. v. Taro Pharms. Inc., 25-1858 (D.N.J.) |
Mar. 13, 2025 |
Hon. Madeline Cox Arleo |
Opzelura®
(ruxolitinib cream) |
10,758,543
10,869,870
11,219,624
11,510,923
11,571,425
11,590,136
11,590,137 |
| Incyte Corp. v. Hikma Pharms. USA Inc., 25-1859 (D.N.J.) |
Mar. 13, 2025 |
Hon. Christine P. O’Hearn |
Jakafi®
(ruxolitinib tablets) |
7,598,257
8,415,362
8,722,693
8,822,481
8,829,013 |
| Opus Genetics, Inc. v. Sandoz Inc., 25-1895 (D.N.J.) |
Mar. 14, 2025 |
Hon. Zahid N. Quraishi |
Ryzumvi™
(phentolamine ophthalmic solution) |
9,795,560
10,278,918
10,772,829
11,090,261
11,844,858
11,400,077
12,201,615
12,201,616 |
| Sumitomo Pharma Switzerland GmbH v. Aizant Drug Research Solutions Private Ltd., 25-0343 (D. Del.) |
Mar. 19, 2025 |
Hon. Maryellen Noreika |
Orgovyx®
(relugolix tablets) |
11,795,178
12,097,198
12,144,809 |
| Sumitomo Pharma Switzerland GmbH v. Hetero Labs Ltd., 25-0344 (D. Del.) |
Mar. 19, 2025 |
Hon. Maryellen Noreika |
Orgovyx®
(relugolix tablets) |
11,795,178
12,097,198
12,144,809 |
| Sumitomo Pharma Switzerland GmbH v. MSN Labs. Pvt. Ltd., 25-0345 (D. Del.) |
Mar. 19, 2025 |
Hon. Maryellen Noreika |
Orgovyx®
(relugolix tablets) |
11,795,178
12,097,198 |
| Exelixis, Inc. v. MSN Labs. Private Ltd., 25-0346 (D. Del.) |
Mar. 19, 2025 |
Hon. Richard G. Andrews |
Cabometyx®
(cabozantinib tablets) |
12,128,039 |
| Impax Labs., LLC v. Qilu Pharm. Co., Ltd., 25-1962 (D.N.J.) |
Mar. 19, 2025 |
Hon. Evelyn Padin |
Rytary®
(carbidopa / levodopa extended-release capsules) |
8,557,283
9,089,608
9,463,246
9,533,046
9,901,640 |
| Impax Labs., LLC v. Biocon Pharma Ltd., 25-1968 (D.N.J.) |
Mar. 19, 2025 |
Hon. Evelyn Padin |
Rytary®
(carbidopa / levodopa extended-release capsules) |
8,557,283
9,089,608
9,463,246
9,533,046
9,901,640 |
| Bayer Pharma AG v. Lupin Ltd., 25-0349 (D. Del.) |
Mar. 20, 2025 |
Hon. Richard G. Andrews |
Xarelto®
(rivaroxaban tablets) |
10,828,310 |
| Novartis Pharms. Corp. v. Alembic Pharms. Ltd., 25-0350 (D. Del.) |
Mar. 20, 2025 |
Hon. Jennifer L. Hall |
Kisqali®
(ribociclib tablets) |
8,324,225
8,415,355
8,685,980
8,962,630
9,416,136 |
| Bausch Health Ireland Ltd. v. Taro Pharms. Inc., 25-2000 (D.N.J.) |
Mar. 20, 2025 |
Hon. Madeline Cox Arleo |
Cabtreo®
(clindamycin phosphate / adapalene / benzoyl peroxide topical gel) |
8,288,434
9,561,208
10,220,049
10,624,918
11,389,467
12,128,059
12,133,859
12,138,278 |
| Eli Lilly & Co. v. Humanwell Pharm. US, Inc., 25-0362 (E.D. Mo.) |
Mar. 21, 2025 |
Hon. Stephen R. Clark |
Reyvow®
(lasmiditan tablets) |
11,053,214 |
| Eli Lilly & Co. v. Humanwell Pharm. US, Inc., 25-2020 (D.N.J.) |
Mar. 21, 2025 |
Hon. Evelyn Padin |
Reyvow®
(lasmiditan tablets) |
11,053,214 |
| Heron Therapeutics, Inc. v. Qilu Pharm. Co., Ltd., 25-0357 (D. Del.) |
Mar. 21, 2025 |
Hon William C. Bryson |
Aponvie®
(aprepitant injection) |
9,561,229
9,808,465
9,974,742
9,974,793
9,974,794
10,500,208
10,624,850
10,953,018
11,173,118
11,744,800
11,878,074
12,115,254
12,115,255 |
| Janssen Sciences Ireland Unlimited Co. v. Laurus Labs, Ltd., 25-2049 (D.N.J.) |
Mar. 24, 2025 |
Hon. Zahid N. Quraishi |
Complera®
(emtricitabine / rilpivirine / tenofovir disoproxil fumarate tablets) |
10,857,102
8,618,291
8,101,752 |
| Calliditas Therapeutics AB v. Zydus Pharms. (USA) Inc., 25-0368 (D. Del.) |
Mar. 25, 2025 |
Hon. Colm F. Connolly |
Tarpeyo®
(budesonide delayed-release capsules) |
11,896,719
12,171,882
12,171,883 |
| Urovant Sciences GmbH v. Apotex Inc., 25-0372 (D. Del.) |
Mar. 26, 2025 |
Hon. Gregory B. Williams |
Gemtesa®
(vibegron tablets) |
12,102,638 |
| Urovant Sciences GmbH v. Intas Pharms. Ltd., 25-0373 (D. Del.) |
Mar. 26, 2025 |
Hon. Gregory B. Williams |
Gemtesa®
(vibegron tablets) |
12,102,638 |
| Nevakar Injectables, Inc. v. InfoRLife SA, 25-2086 (D.N.J.) |
Mar. 26, 2025 |
Hon. Julien Xavier Neals |
norepinephrine bitartrate in sodium chloride for injection |
12,245,996 |
| Salix Pharms., Inc. v. Mylan Pharms. Inc., 25-0024 (N.D.W.V.) |
Mar. 26, 2025 |
Hon. Thomas S. Kleeh |
Xifaxan®
(rifaximin tablets) |
11,779,571
11,564,912
8,193,196 |
| Sumitomo Pharma Switzerland GmbH v. Annora Pharma Private Ltd., 25-0380 (D. Del.) |
Mar. 27, 2025 |
Hon. Maryellen Noreika |
Myfembree®
(estradiol / norethindrone acetate / relugolix tablets) |
11,795,178
11,033,551
11,957,684
11,793,812 |
| Urovant Sciences GmbH v. Intas Pharms. Ltd., 25-0163 (E.D.N.C.) |
Mar. 27, 2025 |
Hon. Louise Wood Flanagan |
Gemtesa®
(vibegron tablets) |
12,102,638 |
| UCB Inc. v. Hikma Pharms. PLC, 25-0382 (D. Del.) |
Mar. 28, 2025 |
Hon. Jennifer L. Hall |
Nayzilam®
(midazolam nasal spray) |
8,217,033
8,809,322
9,289,432
9,687,495 |
| Almirall, LLC v. Taro Pharms., Inc., 25-0385 (D. Del.) |
Mar. 28, 2025 |
Hon. Colm F. Connolly |
Klisyri®
(tirbanibulin topical ointment) |
7,300,931
7,851,470
10,323,001
10,617,693
10,669,236
11,497,750 |
| InfoRLife SA v. Sagent Pharms. (Inc.), 25-0387 (D. Del.) |
Mar. 28, 2025 |
Hon. Colm F. Connolly |
norepinephrine bitartrate in sodium chloride for injection |
10,888,534 |
